Search by Character/Letter String, CAS, JECFA, FEMA, FL-No or Industry Name
Industry Name
CAS
4-Butylthiazole 53833-33-3 15.118
3-(Methylthio)methylthiophene 61675-72-7 1765 4184 15.126
2-Propionyl-2-thiazoline 29926-42-9 1760 4064 15.128
2,5-Dihydroxy-1,4-dithiane 40018-26-6 0550 3826 15.134
2-Ethyl-4,6-dimethyl-dihydro-1,3,5-dithiazine 54717-14-5; 54717-13-4 2116 4667 15.135
3-Ammonium isovalerate 7563-33-9 1203 2054 16.001
diammonium sulfide 12135-76-1 2053 16.002
Nonanoyl 4-hydroxy-3-methoxybenzylamide 2444-46-4 1599 2787 16.006
Hydrogen sulfide 7783-06-4 3779 16.007
Ammonia 7664-41-7 4494 16.009
Glycyrrhizic acid 1405-86-3 16.012
N-Ethyl 2-isopropyl-5-methylcyclohexanecarboxamide 39711-79-0 1601 3455 16.013
Ethyl methylphenylglycidate 77-83-8 1577 2444 16.015
Caffeine 58-08-2 2224 16.016
Ethyl 3-phenyl-2,3-epoxypropionate 121-39-1 1576 2454 16.018
Thiamine hydrochloride 67-03-8 1030 3322 16.027
2-Methyl-4-propyl-1,3-oxathiane 67715-80-4 0464 3578 16.030
Theobromine 83-67-0 3591 16.032
Potassium 2-(1'-ethoxy)ethoxypropanoate 100743-68-8 0933 3752 16.039
Ethyl methyl-p-tolylglycidate 74367-97-8 1578 3757 16.040
Sodium 2-(4-methoxyphenoxy)propanoate 150436-68-3 1029 3773 16.041
beta-Caryophyllene oxide 1139-30-6 1575 4085 16.043
Ammonium chloride 12125-02-9 4494 16.048
1,6-Hexalactam 105-60-2 1594 4235 16.052
2-Isopropyl-N,2,3-trimethylbutyramide 51115-67-4 1595 3804 16.053
Sclareolide 564-20-5 1165 3794 16.055
Taurine 107-35-7 1435 3813 16.056
Naringin 10236-47-2 16.058
Ammonium hydrogen sulphide 12124-99-1 2053 16.059
Glycyrrhizic acid, ammoniated 53956-04-0 2528 16.060
Neohesperidin dihydrochalcone 20702-77-6 3811 16.061
trans-2-methyl-4-propyl-1,3-oxathiane 59324-17-3 16.062
Sodium diacetate 126-96-5 3900 16.073
Ethyl vanillin beta-D-glucopyranoside 122397-96-0 0892 3801 16.075
Tannic acid 1401-55-4; 72401-53-7 3042 16.080
Sucrose octaacetate 126-14-7 3038 16.081
(-)-Homoeriodictyol sodium salt 462631-45-4 2256 4228 16.083
N-Benzoylanthranilic acid 579-93-1 1552 4078 16.087
l-Menthyl methyl ether 1565-76-0 1415 4054 16.088
Ferric ammonium citrate 1185-57-5 16.089
N-[2-(3,4-Dimethoxyphenyl)ethyl]-3,4-diemethoxycinnamic acid amide 69444-90-2 1777 4310 16.090
N-Isobutyl (E,E)-2,4-decadienamide 18836-52-7 1598 4148 16.091
(+/-) N,N-Dimethyl menthyl succinamide 544714-08-1 1602 4230 16.092
N-3,7-Dimethyl-2,6-octadienyl cyclopropylcarboxamide 744251-93-2 1779 4267 16.095
Ferrous lactate 5905-52-2; 85993-25-5 4699 16.096
5,7-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-chroman-4-one 69097-99-0; 520-33-2 2024 4313 16.097
N-(Heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide 745047-51-2 1767 4232 16.098
N1-(2,4-Dimethoxybenzyl)-N2-(2-(pyridin-2-yl)ethyl)oxalamide 745047-53-4 1768 4233 16.099
N1-(2-Methoxy-4-methylbenzyl)-N2-(2-(5-methylpyridin-2-yl)ethyl)oxalamide 745047-94-3 1769 4234 16.100
N1-(2-Methoxy-4-methylbenzyl)-N2-(2-(pyridin-2-yl)ethyl)oxalamide 745047-97-6 1770 4231 16.101
N-(2-Hydroxyethyl)galactonamide 686298-93-1 1772 4254 16.102
N-Lactoyl ethanolamine 5422-34-4 1774 4256 16.103
N-Lactoyl ethanolamine phosphate 782498-03-7 1775 4257 16.104
N-Gluconyl ethanolamine phosphate 791807-20-0 1773 4255 16.105
(+/-)-N-Lactoyl tyramine 781674-18-8 2007 4550 16.107
3-(4-Hydroxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one 60-82-2 2022 4390 16.109
Naringin dihydrochalcone 18916-17-1 2208 4495 16.110
N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide 68489-14-5 1776 4309 16.111
Trilobatin 4192-90-9 2171 4674 16.112
Rebaudioside A 58543-16-1 4601 16.113
(+/-)-cis- and trans-2-Pentyl-4-propyl-1,3-oxathiane 59323-81-8 1943 4499 16.114
Cyclopropanecarboxylic acid (2-isopropyl-5-methyl-cyclohexyl)-amide 958660-02-1; 958660-04-3 2006 4558 16.115
4-Amino-5,6-dimethylthieno[2,3-d]pyrimidin-2(1H)-one (hydrochloride) 121746-18-7; 1033366-59-4 2117 4669 16.116
N-p-Benzene acetonitrile-menthane-carboxamide 852379-28-3 2009 4496 16.117
N-(2-(Pyridin-2-yl)ethyl)-3-p-menthanecarboxamide 847565-09-7 2008 4549 16.118
N-(2-Methylcyclohexyl)-2,3,4,5,6-pentafluorobenzamide 1003050-32-5 2081 4678 16.119
(2E,6E/Z,8E)-N-(2-Methylpropyl)-2,6,8-decatrienamide 25394-57-4; 504-48-3 2077 4668 16.121
(+/-) 4-Methyl-2-propyl-1,3-oxathiane 1064678-08-5 2089 4677 16.122
(1R,2S,5R)-N-(4-Methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide 68489-09-8 2079 4681 16.123
(2S,5R)-N-[4-(2-Amino-2-oxoethyl)phenyl]-5-methyl-2-(propan-2-yl)cyclohexanecarboxamide 1119711-29-3 2078 4684 16.125
3[(4-Amino-2,2-dioxido-1H-2,1,3-benzothiadiazin-5-yl)oxy]-2,2-dimethyl-N-propylpropanamide 1093200-92-0 2082 4701 16.126
3-(1-((3,5-Dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-1-(3-hydroxybenzyl)-imidazolidine-2,4-dione 1119831-25-2 2161 4725 16.127
4-Amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acid (and its hemisulfate monohydrate salt) 1359963-68-0; 1460210-04-1 2204 4774 16.130
2-(4-Methylphenoxy)-N-(1H-pyrazol-3-yl)-N-(thiophen-2-ylmethyl)acetamide 1374760-95-8 2237 4809 16.133
Alanine 107-95-9 1418 3252 17.001
L-Alanine 56-41-7 1437 3818 17.002
L-Arginine 74-79-3 1438 3819 17.003
L-Aspartic acid 56-84-8 1429 3656 17.005
Cystine 56-89-3 17.006
L-Glutamine 56-85-9 1430 3684 17.007
L-Histidine 71-00-1 1431 3694 17.008
dl-Isoleucine 443-79-8 1422 3295 17.010
Leucine 61-90-5; 328-39-2; 328-38-1 1423 3297 17.012
DL-Lysine 70-54-2; 923-27-3 1439 3847 17.013
DL-Methionine 59-51-8; 348-67-4 1424 3301 17.014
DL-(3-Amino-3-carboxypropyl)dimethylsufonium chloride 3493-12-7; 1115-84-0 1427 3445 17.015
DL-Phenylalanine 150-30-1; 673-06-3 1432 3726 17.017
L-Phenylalanine 63-91-2 1428 3585 17.018
Proline 147-85-3; 609-36-9; 344-25-2 1425 3319 17.019
Serine 302-84-1 17.020
Threonine 80-68-2; 632-20-2 2119 4710 17.021
L-Thyrosine 60-18-4 1434 3736 17.022
Valine 516-06-3; 640-68-6 1426 3444 17.023
DL-Alanine 302-72-7; 338-69-2 1437 3818 17.024
L-Lysine 56-87-1 1439 3847 17.026
l-Methionine 63-68-3 1424 3301 17.027
l-Valine 72-18-4 1426 3444 17.028
l-Lysine monochlorhydrate 657-27-2 17.031
l-Cysteine hydrochloride 52-89-1 3263 17.032
l-Cysteine 52-90-4 1419 3263 17.033
Agreement Disclaimer
The IOFI secretariat has prepared the GRL with the intention to be complete and up-to-date with the available safety information. IOFI cannot be held liable for errors or omissions in this document. Neither IOFI or any individual member or officer can be held liable for any loss or damage as a result of relying on the IOFI GRL.

Please report any potential errors and forward suggested corrections to the IOFI secretariat.

The Terms and Conditions of Use file_download

I understand and accept the Terms and Conditions of Use.